ID   BC31
AC   CVCL_9U95
DR   TKG; TKG 0324
DR   Wikidata; Q54795221
RX   PubMed=381090;
RX   PubMed=29732388;
CC   Transformant: ChEBI; CHEBI_91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
CH   CVCL_ZF55 ! BC31ad
CH   CVCL_ZF56 ! BC31nonad
//
RX   PubMed=381090; DOI=10.20772/cancersci1959.70.3_305;
RA   Hashimoto, Yoshiyuki
RA   Kitagawa, Hisayo S.
RT   "Antigen characteristics of nitrosamine-induced urinary bladder cancer
RT   in rats.";
RL   Gann 70:305-314(1979).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350;
RA   Zuiverloon, Tahlita C.M.
RA   de Jong, Florus Christiaan
RA   Costello, James C.
RA   Theodorescu, Dan
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//